Allworth Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,781
Closed -$56K – 5448
2026
Q2
$56K Sell
1,781
-24,681
-93% -$728K ﹤0.01% 2383
2026
Q1
$655K Sell
26,462
-2,127
-7% -$50.7K ﹤0.01% 849
2025
Q4
$667K Sell
28,589
-706
-2% -$15.7K ﹤0.01% 819
2025
Q3
$577K Buy
29,295
+8,323
+40% +$171K ﹤0.01% 839
2025
Q2
$455K Buy
20,972
+300
+1% +$7.08K ﹤0.01% 865
2025
Q1
$6.19K Hold
267
– – ﹤0.01% 2650
2024
Q4
$6.11K Sell
267
-94
-26% -$2.02K ﹤0.01% 2665
2024
Q3
$7.18K Hold
361
– – ﹤0.01% 2410
2024
Q2
$6.12K Buy
361
+109
+43% +$1.7K ﹤0.01% 2425
2024
Q1
$4.02K Sell
252
-19
-7% -$286 ﹤0.01% 2498
2023
Q4
$4.56K Buy
271
+246
+984% +$3.36K ﹤0.01% 2308
2023
Q3
$293 Buy
+25
New +$334 ﹤0.01% 3175
2023
Q1
– Sell
-68
Closed -$1.26K – 3210
2022
Q4
$1.26K Buy
68
+4
+6% +$62 ﹤0.01% 2397
2022
Q3
$1K Buy
+64
New +$758 ﹤0.01% 2345

Other funds holding CPRX

Allworth Financial's CPRX Position: Q3 2026 in Review

Allworth Financial sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 1,781 shares — an estimated $56K sold.

Allworth Financial first reported a position in CPRX in Q3 2022 and held it in 14 quarters. The position peaked at $667K in Q4 2025. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

  • Allworth Financial reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Allworth Financial sold 1,781 Catalyst Pharmaceutical shares in Q3 2026, an estimated $56K.
  • Allworth Financial first reported a position in Catalyst Pharmaceutical in Q3 2022 and held it in 14 quarters.
  • Allworth Financial's Catalyst Pharmaceutical position peaked at $667K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.